Targeted proton blast tested for tough prostate cancers
NCT ID NCT06591819
First seen Feb 05, 2026 · Last updated Apr 10, 2026 · Updated 8 times
Summary
This study is testing a shorter, more intense course of targeted radiation therapy for men with high-risk or aggressive intermediate-risk prostate cancer. It combines two radiation techniques—proton therapy to the pelvis and a high-dose internal boost—to try to better control the cancer. The main goal is to see if this approach is safe and causes acceptable side effects while also checking if it keeps PSA levels low.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.